Related Experiment Video
Updated: Jul 19, 2026

07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Insulin association in neutral solutions studied by light scattering.
1Department of Chemistry, Risø National Laboratory and Roskilde University, DK-4000 Roskilde, Denmark.
Biophysical Chemistry
|February 1, 1991
Summary
Zinc stabilizes insulin hexamers, influencing its molecular weight and distribution. Sulfated insulin remains monomeric, while zinc-free and 2Zn insulins show intermediate states, highlighting zinc's crucial role in insulin structure.
Area of Science:
- Biochemistry
- Protein chemistry
- Structural biology
Background:
- Insulin exists in various oligomeric states, influencing its biological activity.
- Zinc is known to play a role in insulin storage and formulation.
Purpose of the Study:
- To investigate the molecular weight and distribution of sulfated, zinc-free, and 2Zn insulins.
- To quantify the effect of zinc on insulin oligomerization.
Main Methods:
- Light scattering
- Refractometry
- Size-exclusion chromatography
- Dynamic light scattering
Main Results:
- Sulfated insulin was monomeric across the tested concentration range.
- Zinc-free and 2Zn insulins exhibited molecular weights between monomeric and hexameric states.
- Zinc significantly stabilizes the insulin hexamer, increasing the dimer-hexamer equilibrium constant by approximately 400-fold.
- The hydrodynamic radius of 2Zn insulin was measured at 5.6 nm, consistent with the hexameric form.
Conclusions:
- Zinc is a critical stabilizer of the insulin hexamer.
- The oligomeric state of insulin is concentration-dependent and influenced by sulfation and zinc content.
Related Concept Videos
Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
